Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - An observational study in Israel suggests additional protection from a 3rd dose of the Pfizer vaccine in individuals 60 years of age or older.

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

An observational study in Israel suggests additional protection from a 3rd dose of the Pfizer vaccine in individuals 60 years of age or older.

An observational study in Israel suggests additional protection from a 3rd dose of the Pfizer vaccine in individuals 60 years of age or older.

Zouhair Souissi

Bibliographie

16 septembre 2021

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel – New England Journal of Medicine

The post An observational study in Israel suggests additional protection from a 3rd dose of the Pfizer vaccine in individuals 60 years of age or older. appeared first on Links Medicus.

Lu 633 fois

Taille de police Réduire la taille de la police Augmenter la taille de police

Évaluer cet élément

1
2
3
4
5

(0 Votes)

Plus dans cette catégorie : « Case series: Vaccine-induced thrombocytopenia with severe headache may precede cerebral venous sinus thrombosis by several days – patients with severe headache 5 to 20 days after adenovirus vector vaccination against Covid-19 should undergo immediate test COVID vaccine effects wane over time but still prevent death and severe illness. »

About Author

Zouhair Souissi

Dernier de Zouhair Souissi

Recherche